AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 79 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,608,635 | +315.7% | 107,601 | +128.9% | 0.01% | +400.0% |
| Q3 2022 | $387,000 | -72.3% | 47,002 | -77.8% | 0.00% | -66.7% |
| Q2 2021 | $1,395,000 | +258.6% | 211,723 | +298.9% | 0.00% | +200.0% |
| Q1 2021 | $389,000 | -32.6% | 53,075 | -46.9% | 0.00% | -50.0% |
| Q4 2020 | $577,000 | -27.3% | 99,985 | -35.1% | 0.00% | -50.0% |
| Q2 2020 | $794,000 | +1520.4% | 154,108 | +1046.9% | 0.00% | – |
| Q1 2020 | $49,000 | – | 13,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 835,000 | $6,112,000 | 0.90% |
| NEA Management Company, LLC | 3,952,958 | $28,936,000 | 0.65% |
| X-Square Capital, LLC | 101,248 | $741,000 | 0.34% |
| Monashee Investment Management LLC | 250,000 | $1,830,000 | 0.28% |
| Cormorant Asset Management, LP | 1,500,000 | $10,980,000 | 0.24% |
| CLOUGH CAPITAL PARTNERS L P | 300,000 | $2,196,000 | 0.10% |
| Maven Securities LTD | 225,000 | $1,604,000 | 0.07% |
| XTX Topco Ltd | 15,292 | $112,000 | 0.05% |
| PERSONAL CFO SOLUTIONS, LLC | 23,000 | $168,000 | 0.04% |
| PDT Partners, LLC | 46,666 | $342,000 | 0.02% |